Bridging The Gap Between Primary And Secondary IBD Patient Care In A Changing NHS Landscape

With the ICS structure coming into full effect on 1st July 2022, it is one of the most impactful changes in legislation and structure to the NHS in our lifetime; disruptive changes create opportunities.

At BSG LIVE ’22, Tillotts Pharma UK organised a panel discussion with Dr Peter Irving, Dr Charlie Andrews and David Thorne. The panel gave their expert opinions from their diverse range of NHS backgrounds and roles to discuss how collaborative practice across primary and secondary care could impact IBD patient care and the opportunities the ICS structure could create.


This content is intended for UK healthcare professionals


NU-01826 July 2022